Two-phase orthodontics is one of the more contested subjects in the field, and parents are often given confident answers from both directions — that early treatment is essential, or that it is unnecessary expense. Neither blanket statement holds up.
The accurate answer is that early treatment is clearly justified for some findings, clearly unnecessary for others, and debatable for a specific set of cases in between. This article explains which is which, including where the evidence contradicts common practice.
What the Two Phases Are
Phase One happens in the mixed dentition, roughly ages six to nine, while both primary and permanent teeth are present. Its objectives are skeletal and functional rather than cosmetic: developing arch width, correcting crossbites, managing space, addressing habits, and supporting breathing and function. It typically runs six to twelve months, followed by a period of monitoring.
Phase Two begins once most or all permanent teeth have erupted, usually in the early teens. Its objective is comprehensive alignment and finishing of the bite, with braces or aligners, typically over eighteen to thirty months.
A single-phase approach skips the first and does everything in the second.
Where Early Treatment Is Clearly Justified
These findings have a genuine rationale for treating early, and waiting has costs:
• Posterior crossbite with a functional shift. The lower jaw slides sideways to find a bite, and left uncorrected this asymmetric function is associated with asymmetric growth. Correcting it early is straightforward; correcting the consequences later is not.
• Anterior crossbite, where lower teeth sit in front of upper teeth, which can cause enamel wear and gingival recession and worsens with continued growth.
• Transverse maxillary deficiency. Expansion is dramatically easier before the midpalatal suture interdigitates, and it also reduces nasal airway resistance.
• Severely protrusive upper incisors. This is the one area where the evidence for early treatment is specific and favorable — early correction reduces the risk of traumatic injury to prominent front teeth, which is a real and permanent harm.
• Persistent harmful habits — thumb or finger sucking past roughly age four — where the arch effects accumulate with continued duration.
• Early loss of primary teeth, where a space maintainer prevents a much larger problem.
• Impacted or ectopically erupting permanent teeth, where early intervention can redirect eruption.
• Sleep-disordered breathing with a contributing skeletal finding, where the timing of growth is the reason not to wait.
Where the Evidence Argues for Waiting
This is the part that deserves more attention than it usually gets.
Several well-designed randomized trials — conducted in Florida, North Carolina, and Manchester — compared early two-phase treatment against a single phase in adolescence for Class II malocclusion, the common pattern where the upper teeth sit well ahead of the lower. The findings were consistent and, for many clinicians, unwelcome: two-phase treatment did not produce better final occlusal outcomes, did not reduce total treatment time, did not reduce the need for extractions or surgery, and generally cost more. The clear benefit that did emerge was a reduction in incisor trauma for children with markedly protrusive front teeth.
That is a meaningful benefit, and it justifies early treatment in that specific group. It does not justify routine early treatment for Class II generally.
We mention this because it is an example of published evidence cutting against a profitable practice pattern, and parents deserve to hear it from the clinician recommending treatment rather than discover it later. When we recommend Phase One, we should be able to say which finding justifies it.
The Airway Consideration
The trials above examined dental and skeletal outcomes. They were not designed to assess airway or breathing outcomes, and this is where airway-focused practice makes a distinct argument.
Transverse development is time-sensitive in a way that Class II correction is not — the mandible continues growing into adolescence, while the midpalatal suture becomes progressively harder to separate. So the case for early expansion rests on different reasoning than the case for early Class II correction, and the Class II trial results do not transfer to it.
We hold that argument honestly, including its limits: the evidence that expansion reduces nasal resistance and improves current sleep-disordered breathing measures is reasonable; the evidence that it changes adult outcomes does not exist. We recommend early expansion on the strength of the first, not the second.
Related reading: Does My Child Need Palatal Expansion? Signs, Timing, and What It Actually Does.
Questions Worth Asking Before Agreeing to Phase One
If early treatment has been recommended for your child, these questions will clarify quickly whether the recommendation is specific or routine:
• What specific finding is this treating? A named finding, not “getting ahead of it.”
• What happens if we wait until the permanent teeth are in?
• Will my child still need Phase Two? (Usually yes — an answer of “probably not” warrants a second opinion.)
• What is the total cost of both phases combined, compared with a single phase?
• How will we know whether Phase One worked? What is being measured?
• Is there an airway or breathing rationale, and what examination supports it?
Clear, specific answers indicate a considered recommendation. Vague answers usually indicate a protocol applied uniformly.
What Early Treatment Does Not Do
• It does not usually eliminate the need for Phase Two. Early treatment addresses skeletal and functional issues; aligning permanent teeth is separate.
• It does not reliably shorten total treatment time. Combined across both phases, the time in appliances is often longer.
• It does not prevent all extractions, though it can reduce the likelihood in some cases.
• It does not guarantee a stable result. Retention and myofunctional support determine stability more than the timing of treatment.
How We Approach It
We evaluate children from age 3 and recommend an orthodontic evaluation by age 7, consistent with the American Association of Orthodontists. What follows from that evaluation is often nothing — monitoring at recall visits, with growth watched rather than assumed.
When we do recommend early treatment, we name the finding, explain what waiting would cost, state plainly whether a second phase is still expected, and give a combined cost for both. A recommendation that cannot survive those four questions is not one we should be making.
Frequently Asked Questions
Is Phase One a waste of money? Not when it targets a finding that genuinely benefits from early correction — crossbite with a functional shift, transverse deficiency, severely protrusive incisors, or a persistent habit. It is poor value when applied routinely to cases that would do as well with a single later phase.
My orthodontist says Phase One will prevent extractions. Is that true? Sometimes. Arch development can reduce the likelihood of extraction in borderline cases. It cannot be promised in advance, and severe crowding may still require extraction regardless of early treatment.
My child is 7 with no obvious problems. Should we still have an evaluation? Yes. The purpose of evaluating at 7 is to identify the children who need something, and the majority of evaluations end with reassurance and a plan to monitor.
→ Schedule a pediatric orthodontic and airway evaluation: (408) 516-1432
About Joint & Airway Analytics
Joint & Airway Analytics is a TMJ, airway, and craniofacial pain practice in San Jose, California, founded and directed by Victor D. Woodlief, DMD. The practice focuses on temporomandibular disorders, sleep-disordered breathing, and orofacial pain, and treats patients from San Jose, Campbell, Los Gatos, Saratoga, Cupertino, Santa Clara, Willow Glen, and the wider Bay Area.
Joint & Airway Analytics
385 S. Monroe Street, San Jose, CA 95128
Phone: (408) 516-1432
Website: www.airwayhealth.net